Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check4 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0, while the study page remains inaccessible with a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide notice says NIH agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. The page continues to display a 403 error instead of the study record.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now shows a 403 Forbidden error page with a minimal header and a Home link. The detailed IPF-PRO/ILD-PRO registry content and study details have been removed.SummaryDifference21%

- Check67 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a new revision of the study record page with potential minor fixes or clarifications.SummaryDifference0.0%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.